Newswise: Latest News

Curious by Nature | Dr. Mohammad Moghimi - Detecting Skin Cancer from Home

Newswise — Mon, 15 Jun 2026 04:00:47 EST

At first glance, a skin abnormality can leave even the most seasoned specialists guessing whether a mole is entirely benign or potentially cancerous. While dermatologists utilize top-tier imaging and borders to make the call, traditional biopsies remain a stressful, invasive, and sometimes hit-or-miss tool for patients.

Curious by Nature | Dr. Josh Currie - Will Humans Ever Be Able to Regrow Limbs?

Newswise — Mon, 15 Jun 2026 03:45:56 EST

If a salamander loses a leg, it grows a perfect, fully functional new one, a feat humans cannot match.

Half of Parents Report Tracking Their Adult Kids, and 1 in 4 Trackers Say It Can Increase Their Anxiety

Michigan Medicine - University of Michigan — Mon, 15 Jun 2026 00:15:00 EST

While tracking tools can provide reassurance, some parents may be crossing a line as their children reach adulthood, according to a new national poll.

ETRI Develops Autonomous 6G Core Network Powered by AI

National Research Council of Science and Technology — Mon, 15 Jun 2026 00:00:16 EST

A Korean research team has developed the "intelligent core" of a 6G network capable of autonomous control through artificial intelligence (AI). This achievement marks the first realization of an "intelligent 6G core" in Korea and represents a significant milestone in advancing next-generation network infrastructure.

Semaglutide Linked to Lower Bone Fracture Risk

Endocrine Society — Sun, 14 Jun 2026 14:45:00 EST

In people with type 2 diabetes, semaglutide was associated with a 15% reduction in bone fractures and greater weight loss compared to other anti-obesity medications, according to a study being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

Menopausal Hormone Therapy Reduces Risk of Low Bone Mineral Density by 69%

Endocrine Society — Sun, 14 Jun 2026 14:45:00 EST

Women on menopausal hormonal therapy face a decreased risk of low bone mineral density compared to those not using it, according to a study being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

More Than Half of Those Who Stop GLP-1s Restart Within a Year

Endocrine Society — Sun, 14 Jun 2026 10:00:00 EST

People prescribed GLP-1 medications are more likely to start-and-stop than most people assume, according to a study being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, IL.

Non-Hormone Medication Addresses Menopausal Symptoms in Women

Endocrine Society — Sun, 14 Jun 2026 10:00:00 EST

The first real-world study of the FDA-approved non-hormone treatment fezolinetant found the menopausal medication improved hot flashes, depression and anxiety in women, according to industry-sponsored research being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

EDCs Found in Breast Milk and Infant Urine Up to Age 6 Months

Endocrine Society — Sat, 13 Jun 2026 16:30:00 EST

Endocrine-disrupting chemicals (EDCs) that interfere with hormones were found in breast milk and in the urine of children from birth up to 6 months, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

Phthalate Exposure in Early Life May Lead to Anxiety in Adult Male Rats

Endocrine Society — Sat, 13 Jun 2026 16:30:00 EST

Male rats that were exposed to the widely used plasticizer di-(2-ethylhexyl) phthalate (DEHP) during early development exhibited increased anxiety behavior as adults, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

Type 1 Diabetes Diagnoses Surge Among Puerto Rican Teens

Endocrine Society — Sat, 13 Jun 2026 14:45:00 EST

The incidence of type 1 diabetes among teens in Puerto Rico more than doubled from 2009 to 2021 and remained elevated through 2024, with an average annual increase of 4.1 percent, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

Testosterone Alone Is Not a Replacement for Lifestyle Changes in Older Men at Risk of T2D

Endocrine Society — Sat, 13 Jun 2026 14:45:00 EST

Testosterone treatment may improve body composition, glucose metabolism and sexual desire in some older men at high risk of type 2 diabetes (T2D), but the benefits require engagement in a lifestyle program, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

Testosterone Therapy in Men May Be Overprescribed, Inconsistent with Clinical Guidelines

Endocrine Society — Sat, 13 Jun 2026 14:45:00 EST

Only a small number of men who were prescribed testosterone therapy received appropriate, guideline-concordant diagnostic testing, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill, by Sophia Sinha, M.D., clinical assistant professor at the University of Michigan in Ann Arbor, Mich.

Women's Thyroid Cancer Risk May Be Linked to Reproductive Lifespan and Hormone Therapy

Endocrine Society — Sat, 13 Jun 2026 14:45:00 EST

Longer lifetime exposure to female hormones may increase the risk of thyroid cancer in women, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill. The research suggests reproductive and hormonal factors may be involved in thyroid carcinogenesis.

Diabetes Substantially Increases Mortality Risk for Organ Transplant Recipients

Endocrine Society — Sat, 13 Jun 2026 10:45:00 EST

People with an organ transplant who develop or have existing diabetes are more likely to die than those without diabetes, according to a comprehensive analysis of solid-organ transplant recipients, which is being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

Sugar-Free Diets May Disrupt Gut Microbiome

Endocrine Society — Sat, 13 Jun 2026 10:45:00 EST

Eliminating sugar from your diet may be more detrimental than previously thought, according to an animal study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

Exercise Decreases Among People Taking GLP-1 Medication

Endocrine Society — Sat, 13 Jun 2026 10:30:00 EST

Adults with obesity losing weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which is essential to protect muscle, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

AI Model Identifies Patients at Risk of Underdiagnosed Cause of High Blood Pressure

Endocrine Society — Sat, 13 Jun 2026 10:30:00 EST

A study of a new AI model examining 30 years of routine electronic health records (EHR) data could improve screening for primary aldosteronism, a leading cause of high blood pressure that is often unrecognized but increases patients' risk of cardiovascular complications, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

Not All Children with Early Puberty Need the Same Level of Testing or Treatment

Endocrine Society — Sat, 13 Jun 2026 09:00:00 EST

Some subgroups of children with precocious puberty--such as older girls with slowly progressing puberty--may not need the same level of testing or treatment, according to a new Endocrine Society Clinical Practice Guideline released today.

The Brain's Power to Heal Takes Center Stage in World Cup Opener

Houston Methodist — Fri, 12 Jun 2026 21:05:17 EST

Protective headgear scored a moment in the international spotlight as Mexico's Raul Jimenez netted his first World Cup goal during Thursday's opener in Guadalajara, Mexico. The striker has worn a custom headband on the pitch since recovering from a life-threatening skull fracture and brain bleed, the result of a head collision with an opposing player, during an English Premier League match in 2020.

PreludeDx(tm) Achieves New Milestones for DCIS Patients and DCISionRT(r) Testing

PreludeDx — Fri, 12 Jun 2026 20:55:34 EST

Prelude Corporation (PreludeDx(tm)), a leader in precision diagnostics for breast cancer, today highlighted a new milestone for DCISionRT(r), its validated genomic test that provides individualized recurrence risk assessment and predicts radiation therapy benefit for women diagnosed with ductal carcinoma in situ (DCIS).

Researchers Identify Target with Potential to Improve CAR T-Cell Therapy Response in Patients with Blood Cancers

University of Maryland School of Medicine — Fri, 12 Jun 2026 20:55:32 EST

University of Maryland School of Medicine (UMSOM) Researchers have identified a target that may improve the response of CAR T-cell therapy, a treatment for patients with recurrent or difficult to treat blood cancers....

Expert Available to Discuss the Benefits of Outdoor Recreation for Human & Community Health

Cal Poly Humboldt — Fri, 12 Jun 2026 20:55:26 EST

Jefferson Lab Breaks Ground on New Building to Power Next Generation of Scientific Discovery

Thomas Jefferson National Accelerator Facility — Fri, 12 Jun 2026 20:55:25 EST

Jefferson Lab has broken ground on the new Jefferson Lab Data Center (JLDC), which will serve as the future Hub site for the Department of Energy's High Performance Data Facility (HPDF). The news release highlights participation by Under Secretary for Science Dario Gil, federal and state leaders, and details how the JLDC will support DOE's advanced computing, AI and data‑intensive science priorities. The ceremony underscores strong federal-state-local partnerships and the facility's role within DOE's Genesis Mission.

Malcolm Brenner to lead newly-formed Houston Methodist Center for Cell and Gene Therapy

Houston Methodist — Fri, 12 Jun 2026 20:50:57 EST